Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates. 1994

A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
Laboratoire de Chimie Biomoléculaire, Faculté des Sciences de Luminy, Marseille, France.

The synthesis of new potential PFA-BCH-189 conjugate analogues is described and their molecular structure clearly identified through NMR and mass spectra techniques. The anti-HIV-1 activity was determined according to the inhibition of syncytium formation in MT-4 cells, while the anti-HBV activity was determined in infected duck hepatocytes. Both antiviral activities of the PFA-BCH-189 conjugates were much lower than those of the parent BCH-189 (2',3'-dideoxy-3'-thiacytidine) (1). Whereas a prodrug effect, following cleavage and release of the free BCH-189 and PFA, cannot be ruled out, poor cellular permeation of the drug seems to be the most likely reason for the reduced activities against HIV and DHBV. The presence of the PFA moiety appears to be detrimental for both the anti-HIV and anti-DHBV activity of PFA-BCH-189 cases.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004372 Ducks A water bird in the order Anseriformes (subfamily Anatinae (true ducks)) with a broad blunt bill, short legs, webbed feet, and a waddling gait. Duck
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass

Related Publications

A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
October 1995, Antiviral research,
A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
September 2009, Bioorganic & medicinal chemistry,
A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
July 2000, Nucleosides, nucleotides & nucleic acids,
A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
January 1999, Nucleosides & nucleotides,
A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
March 1996, Antimicrobial agents and chemotherapy,
A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
May 2012, Journal of medicinal chemistry,
A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
December 2010, International journal of antimicrobial agents,
A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
July 1994, Journal of medicinal chemistry,
A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
May 2009, Nucleosides, nucleotides & nucleic acids,
A S Charvet, and F Turin, and P Faury, and O Hantz, and M Camplo, and N Mourier, and P Berthillon, and J C Graciet, and J C Chermann, and C Trépo
July 2011, Chemical biology & drug design,
Copied contents to your clipboard!